Reproductive gains as hypothesis-generating findings: while favorable exploratory findings are observed in outcomes such as menstrual regularity, androgenic markers, and natural conception/TTP, these findings are generally limited by small sample sizes, restricted follow-up windows, and a lack of gold-standard ovulatory measurements
In most cases, the symptoms are symmetrical and initially limited to the toes
Additional information Competing interests We declare we have no financial or other contractual agreements that might cause conflicts of interest
Currently, the SURPASS-CVOT trial is evaluating the impact of dulaglutide and tirzepatide on cardiovascular events in patients with T2D (NCT04255433)
Cng dng: Dng m, cp nc, lm sng da, thu nh l chn lng v tng n hi